Overview

Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the ability of [68Ga]N188 to detect nectin-4 overexpression in patients with urothelial carcinoma, especially in patients with recurrent or advanced bladder cancer.
Phase:
N/A
Details
Lead Sponsor:
Beijing Cancer Hospital
Treatments:
Fluorodeoxyglucose F18